| 321568 |
NEURO-ONCOLOGY |
QLIF-20. SKIN CARE PRODUCTS COMPATIBLE WITH TUMOR TREATING FIELDS |
2017-11-01 |
10.1093/neuonc/nox168.830 |
Lacouture Mario, Hershkovich Hadas Sara, Blat Roni, Giladi Moshe, Bomzon Ze’ev, Kirson Eilon D, Weinberg Uri, Palti Yoram |
| 321567 |
NEURO-ONCOLOGY |
TMIC-49. POTASSIUM CHANNEL KIR4.1 AND GLUTAMINE SYNTHETASE ARE DYSREGULATED IN GLIOMA |
2017-11-01 |
10.1093/neuonc/nox168.1037 |
Schirmer Lucas, Liesche Friederike, Barz Melanie, Bette Stefanie, Wiestler Benedikt, Srivastava Rajneesh, Zimmer Claus, Ringel Florian, Rowitch David, Meyer Bernhard, Hemmer Bernhard, Schlegel Jürgen, Gempt Jens |
| 321566 |
NEURO-ONCOLOGY |
DDIS-21. APPLICATION OF A FUNCTIONAL GENETICS APPROACH TO IDENTIFY PHARMACOLOGICAL INHIBITORS OF HIF-1α |
2017-11-01 |
10.1093/neuonc/nox168.256 |
Qi Qichao, Johannessen Tor-Christian Aase, Wang Jian, Li Xingang, Bjerkvig Rolf, Prestegarden Lars |
| 321565 |
NEURO-ONCOLOGY |
DRES-14. OVERCOMING TEMOZOLOMIDE RESISTANCE IN EXPERIMENTAL GLIOMAS: MRI-GUIDED FOCUSED ULTRASOUND-MEDIATED BLOOD-BRAIN BARRIER OPENING FACILITATES THE LOCAL DELIVERY OF LIPOSOME ENCAPSULATED MGMT INHIBITORS |
2017-11-01 |
10.1093/neuonc/nox168.272 |
Roth Patrick, Papachristodoulou Alex, Signorell Rea Deborah, Werner Beat, Brambilla Davide, Grandjean Joanes, Rudin Markus, Martin Ernst, Leroux Jean-Christophe, Weller Michael |
| 321564 |
BMJ OPEN |
Month of birth and risk of autism spectrum disorder: a retrospective cohort of male children born in Israel |
2017-11-01 |
10.1136/bmjopen-2016-014606 |
Shalev Hila, Solt Ido, Chodick Gabriel |
| 321563 |
ENDOCRINE CONNECTIONS |
MEN1 gene mutation with parathyroid carcinoma: first report of a familial case |
2017-11-01 |
10.1530/ec-17-0207 |
Cinque Luigia, Sparaneo Angelo, Salcuni Antonio S, de Martino Danilo, Battista Claudia, Logoluso Francesco, Palumbo Orazio, Cocchi Roberto, Maiello Evaristo, Graziano Paolo, Hendy Geoffrey N, Cole David E C, Scillitani Alfredo, Guarnieri Vito |
| 321562 |
ONCOTARGETS AND THERAPY |
Amatuximab and novel agents targeting mesothelin for solid tumors |
2017-11-01 |
10.2147/ott.s145105 |
Baldo Paolo, Cecco Sara |
| 321561 |
FUSION ENGINEERING AND DESIGN |
Methodological approach for DEMO neutronics in the European PPPT programme: Tools, data and analyses |
2017-11-01 |
10.1016/j.fusengdes.2017.01.053 |
Fischer U., Bachmann C., Catalan J.P., Eade T., Flammini D., Gilbert M., Jaboulay J.-Ch., Konobeev A., Leichtle D., Lu L., Malouch F., Moro F., Pereslavtsev P., Qiu Y., Sanz J., Sauvan P., Stankunas G., Travleev A., Turner A., Ogando F., Palermo I., Villari R. |
| 321560 |
FUSION ENGINEERING AND DESIGN |
Development of a high power Helicon system for DIII-D |
2017-11-01 |
10.1016/j.fusengdes.2017.03.055 |
Tooker J.F., Nagy A., deGrassie J., Moeller C., Hansink M., Fishler B., Murphy C., Anderson J., Torreblanca H. |
| 321559 |
NEURO-ONCOLOGY |
ATIM-19. POPULATION PHARMACOKINETIC (PPK) ANALYSIS OF NIVOLUMAB FLAT AND WEIGHT-BASED DOSING REGIMENS AND ASSOCIATIONS WITH SAFETY IN PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM) TREATED IN CHECKMATE 143 |
2017-11-01 |
10.1093/neuonc/nox168.114 |
Shen Jun, Hruska Matthew, Zwirtes Ricardo, Potter Von, Paliwal Prashni, Roy Amit, Bello Akintunde, Suryawanshi Satyendra, Lim Michael |
